Clinical Trials Directory

Trials / Unknown

UnknownNCT04424420

Mental Effects of Analgesic Drugs: Paracetamol and Ibuprofen

Double Blinded Randomized Placebo Controlled Study on Mental Effects of Analgesic Drugs

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Prof. Jürgen Brockmöller · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The objective of the present study is to study paracetamol effects on social pain and empathy under standardized international conditions (ICH-GCP) for planning, conduction and reporting of clinical pharmaceutical studies in humans. The study included MRI imaging of brain activity, analysis of genomic biomarkers potentially explaining interindividual variation. It is controversial whether the effects are of immediate nature or develop during a period of about 10 days. Therefore, the study is separated into two study phases. Single dosing (SD) is applied in study phase 1 and multiple-dosing (MD) in study phase 2. The study compares paracetamol with placebo and in the study phase 1 also with ibuprofen as analgetically active control.

Conditions

Interventions

TypeNameDescription
DRUGParacetamolParacetamol oral tablet
DRUGIbuprofenIbuprofen oral tablet
DRUGPlacebo oral tabletSugar pill manufactured to mimic the Paracetamol and Ibuprofen.

Timeline

Start date
2019-11-07
Primary completion
2021-03-01
Completion
2021-12-01
First posted
2020-06-11
Last updated
2020-06-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT04424420. Inclusion in this directory is not an endorsement.